Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eugenol is a naturally occurring phenolic compound found in several plants such as clove, cinnamon, and bay leaves. It is widely used as a topical antiseptic and analgesic in dental preparations—often combined with zinc oxide for root canal sealing and pain control—and for the temporary relief of toothaches. Eugenol exhibits anti-inflammatory, antioxidant, antimicrobial, antipyretic, neuroprotective, antifungal, and analgesic properties. Its mechanism of action includes inhibition of sodium channel currents (which underlies its local anesthetic effect), positive allosteric modulation of GABA-A receptors (contributing to general anesthetic properties), inhibition of pro-inflammatory mediators like nitric oxide synthase and cyclooxygenase enzymes, scavenging reactive oxygen species (antioxidant effect), and mild monoamine oxidase inhibition in vitro. Although not currently available in any FDA-approved products as a pharmaceutical drug or over-the-counter medication in the US market, it remains present in unapproved OTC dental products for toothache relief[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eugenol.